HighTower Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

HighTower Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-147,400	Closed	-$765K	–	4110
2024 Q3	$765K	Sell	147,400 -387,987	-72%	-$1.93M	﹤0.01%	2093
2024 Q2	$1.38M	Buy	535,387 +90,000	+20%	+$307K	﹤0.01%	1665
2024 Q1	$2.19M	Buy	445,387 +38,966	+10%	+$231K	﹤0.01%	1385
2023 Q4	$3.57M	Buy	406,421 +116,920	+40%	+$958K	0.01%	1134
2023 Q3	$3.32M	Buy	289,501 +94,451	+48%	+$1.82M	0.01%	1108
2023 Q2	$4.94M	Sell	195,050 -110,209	-36%	-$3.43M	0.01%	912
2023 Q1	$9.83M	Sell	305,259 -186,183	-38%	-$5.8M	0.02%	634
2022 Q4	$9.07M	Sell	491,442 -363,992	-43%	-$8.33M	0.02%	644
2022 Q3	$23.1M	Sell	855,434 -368,728	-30%	-$7.48M	0.06%	304
2022 Q2	$16.9M	Sell	1,224,162 -8,978	-0.7%	-$138K	0.04%	391
2022 Q1	$24M	Buy	1,233,140 +265,422	+27%	+$4.03M	0.05%	332
2021 Q4	$15.8M	Buy	967,718 +107,814	+13%	+$1.8M	0.03%	452
2021 Q3	$24M	Buy	859,904 +277,129	+48%	+$7.91M	0.06%	295
2021 Q2	$17.3M	Sell	582,775 -104,240	-15%	-$3.01M	0.05%	344
2021 Q1	$19.2M	Buy	687,015 +614,315	+845%	+$17M	0.06%	309
2020 Q4	$2.06M	Sell	72,700 -24,234	-25%	-$628K	0.01%	902
2020 Q3	$2.44M	Buy	96,934 +47,734	+97%	+$1.25M	0.01%	810
2020 Q2	$1.2M	Buy	49,200 +5,500	+13%	+$109K	0.01%	1032
2020 Q1	$648K	Buy	43,700 +2,700	+7%	+$55.8K	﹤0.01%	1212
2019 Q4	$665K	Buy	41,000 +12,800	+45%	+$199K	﹤0.01%	1315
2019 Q3	$367K	Buy	28,200 +1,000	+4%	+$12.2K	﹤0.01%	1666
2019 Q2	$352K	Buy	27,200 +1,200	+5%	+$15.1K	﹤0.01%	1706
2019 Q1	$410K	Buy	26,000 +6,000	+30%	+$104K	﹤0.01%	1557
2018 Q4	$403K	Sell	20,000 -2,000	-9%	-$44.1K	﹤0.01%	1462
2018 Q3	$547K	Hold	22,000	–	–	﹤0.01%	1415
2018 Q2	$604K	Hold	22,000	–	–	﹤0.01%	1359
2018 Q1	$678K	Hold	22,000	–	–	0.01%	1280
2017 Q4	$787K	Buy	+22,000	New	+$632K	0.01%	1237